In addition, since it has been recently reported that inhibiting GRP78 expression by the use of specific siRNAs might affect AKT activity and sensitize endometrial cancer cells to apoptosis [37], we evaluated AKT phosphorylation upon metformin treatment. Here, AKT1 is linked to endometrial cancer.